A study set out to assess if Zileuton, an inhibitor of 5-lipoxygenase, is associated with improved disease severity in patients with atopic dermatitis.
Read more at the Journal of the American Academy of Dermatology.
A study set out to assess if Zileuton, an inhibitor of 5-lipoxygenase, is associated with improved disease severity in patients with atopic dermatitis.
Read more at the Journal of the American Academy of Dermatology.
Leave a Reply